Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.

ABSTRACT:

Background

Little is known regarding barriers to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) in low-resource settings, particularly in the era of direct-acting antiviral therapies.

Methods

Between March, 2015-August, 2016, a cross-sectional survey was administered to community-based PWID in Chennai, India to examine the HCV care continuum and associated barriers. Adjusted prevalence ratios (APR) were estimated by multivariable Poisson regression with robust variance.

Results

All participants were male (n = 541); 152 participants had HCV mono-infection and 61 participants had HIV/HCV co-infection. Only one HCV mono-infected and one HIV/HCV co-infected participant was linked to HCV care. Overall, there was moderate knowledge of HCV disease but

SUBMITTER: Patel EU 

PROVIDER: S-EPMC5994190 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature